The Role of Amnion Membrane Allografts in Nipple Preservation

Status Not yet recruiting

Clinical Trial Summary

The overall objective of this proposal is to conduct a randomized-controlled study to determine whether treatment with dehydrated human amnion/chorion membrane (dHACMs) allografts can improve NAC viability in patients undergoing nipple sparing mastectomy (NSM). dHACM allografts are commercially available tissue membranes with biocompatible extracellular matrix and growth factors that have been shown to improve wound healing in patients with chronic and lower extremity wounds. To date, no study has evaluated the impact of dHACMs on NAC preservation following NSM. Investigators hypothesize that subareolar surgical implantation of dHACM allografts at time of NSM will reduce NAC necrosis and improve viability.

Clinical Trial Description

This proposal will be the first clinical trial to evaluate the clinical efficacy of dHACM allografts in NSM. The topic of study not only addresses a critically unmet need in the field of plastic surgery, but also maintains exceptional scientific and clinical merit. This study would be the first to establish dHACM allografts as a novel, innovative, and biologically-based adjunctive mechanism to improve vascularity and wound healing following NSM. Such findings would not only provide the evidence-base for widespread implementation of dHACM allografts in the surgical management of breast patients, but also serve as a catalyst to study the clinical efficacy of these allografts in other plastic surgical patient cohorts. Overall, this proposal aims to serve as a successful translational model incorporating scalable, biologically-based regenerative therapies in a surgical population. Nipple necrosis is a major complication after nipple sparing mastectomy, a procedure that is commonly performed in the human population for gender reassignment surgery and for breast cancer prevention. This study will assess the efficacy of dHACMs can improve nipple viability after NSM. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06073808
Study type	Interventional
Source	Stanford University
Contact	Kassandra Carrion
Phone	650-498-6004
Email	kcarrion@stanford.edu
Status	Not yet recruiting
Phase	N/A
Start date	June 1, 2024
Completion date	August 23, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03618433` - KİNECT® - Video Games Based Physiotherapy Programme in Patients With Breast Cancer Surgery	N/A
Terminated	`NCT05395936` - Mastectomy Flap Temperature Study	N/A
Recruiting	`NCT03757793` - Near-infrared Spectroscopy for Monitoring Tissue Oxygenation in Breast Reconstruction
Completed	`NCT01781299` - Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU	Phase 4
Completed	`NCT01176786` - Reusable Versus Disposable Draping System in Breast Reconstruction Surgery	N/A
Terminated	`NCT00616824` - The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction	Phase 4
Recruiting	`NCT06033456` - Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome	N/A
Recruiting	`NCT05975359` - Assessment of the Interi Manifold in Implant-Based Breast Reconstruction	N/A
Withdrawn	`NCT03135392` - Sensation After Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer	N/A
Recruiting	`NCT01217593` - Ultrasound vs. Predetermined Distance Techniques for Paravertebral Nerve Block in Patients Having Breast Surgery	N/A
Completed	`NCT01231204` - Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks	Phase 4
Recruiting	`NCT05069805` - Comparison of Erector Spinae Plane Block and Pectoral Nerve Block for Acute and Chronic Pain in Mastectomies	N/A
Completed	`NCT01687348` - Lidocaine Pharmacokinetics During Tumescent Infiltrative Anaesthesia for Mastectomy	Phase 3
Completed	`NCT00555503` - Registry of Mastectomy for Breast Cancer Risk Reduction	N/A
Recruiting	`NCT03598712` - Local Compression Seroma DIminution Objective (CLODIS)	Phase 3
Not yet recruiting	`NCT04457167` - Mastectomy With Retention of the Nipple-areola Complex, Robot-assisted or Not, and / or Immediate or Seconday Reconstruction by Latissimus Dorsi Flap, Robot-assisted or Not.	N/A
Recruiting	`NCT05494502` - Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients	N/A
Recruiting	`NCT02894021` - PREvention of Post-mastectomy LYMphoceles by PAdding	N/A
Recruiting	`NCT04891510` - A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery	N/A
Enrolling by invitation	`NCT05658367` - Effect of Aromatherapy Massage on Pain and Anxiety After Mastectomy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Role of Amnion Membrane Allografts in Nipple Preservation — AmnioFix

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms